Drugs and Devices

FDA approves new drug for CIC

On Jan. 29, the U.S. Food and Drug Administration (FDA) approved Trulance (plecanatide) for the treatment of chronic idiopathic constipation. Read more


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares